US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ALT

Altimmune (ALT)

Altimmune Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	18 : 45	PR Newswire (US)	The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc.(ALT) Shareholders	NASDAQ:ALT	Altimmune Inc
2024/05/10	06 : 51	PR Newswire (US)	INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Altimmune Inc. to Contact Law Firm	NASDAQ:ALT	Altimmune Inc
2024/05/10	05 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALT	Altimmune Inc
2024/05/09	20 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALT	Altimmune Inc
2024/05/09	20 : 00	GlobeNewswire Inc.	Altimmune Announces First Quarter 2024 Financial Results and Provides a Business Update	NASDAQ:ALT	Altimmune Inc
2024/05/07	20 : 30	GlobeNewswire Inc.	Altimmune to Participate at Two Upcoming Investor Conferences	NASDAQ:ALT	Altimmune Inc
2024/05/02	20 : 30	GlobeNewswire Inc.	Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024	NASDAQ:ALT	Altimmune Inc
2024/05/01	20 : 30	GlobeNewswire Inc.	Altimmune to Participate at Two Upcoming Conferences	NASDAQ:ALT	Altimmune Inc
2024/04/26	06 : 24	GlobeNewswire Inc.	Altimmune Statement on the Passing of Dr. Stephen Harrison	NASDAQ:ALT	Altimmune Inc
2024/03/27	20 : 00	GlobeNewswire Inc.	Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:ALT	Altimmune Inc
2024/03/27	19 : 57	IH Market News	U.S. Stock Index Futures Point to a Rebound, Oil See Declines in Early Trading	NASDAQ:ALT	Altimmune Inc
2024/03/20	20 : 30	GlobeNewswire Inc.	Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024	NASDAQ:ALT	Altimmune Inc
2024/02/15	02 : 04	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALT	Altimmune Inc
2024/02/14	20 : 37	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALT	Altimmune Inc
2024/02/06	08 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/02/06	08 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/02/06	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/02/02	08 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/02/02	08 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/02/02	08 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/02/02	08 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/02/02	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/01/30	08 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/01/30	08 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/01/30	08 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/01/30	08 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/01/30	08 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/01/27	01 : 49	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ALT	Altimmune Inc
2024/01/05	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc
2024/01/03	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALT	Altimmune Inc

Showing the most relevant articles for your search:NASDAQ:ALT

1 2 3 4 5 6 7 8 9 10 次へ >>

Verizon Communications

American Express

US Dollar vs Sterling

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約